- Federal government must find alternatives to rescheduling hydrocodone combination drugs
- FDA recommends health professionals prescribe no more than 325 mg of acetaminophen per dose
- Mylan launches generic version of Prandin
- Ensuring access to chronic pain medications
- Study: OTC ibuprofen as effective as Rx in treating post-operative pain after having tonsils removed
PITTSBURGH — Mylan has launched a generic version of an opioid painkiller, the company said Wednesday.
Mylan announced the launch of oxycodone hydrochloride tablets in the 5-mg, 15-mg and 30-mg strengths. Mylan is launching the drug under a development and supply agreement with Coastal Pharmaceuticals.
The drug is a generic version of Xanodyne’s Roxicodone, a treatment for moderate to severe pain. Oxycodone hydrochloride tablets had sales of about $325 million during the 12-month period ended in March, according to IMS Health.